ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

248. Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants andchildren. Clin Pediatr (Phila) 1997; 36:311?9.249. Sheridan RL, Weber JM. Mechanical and infectious complications of central venous cannulation in children:lessons learned from a 10-year experience placing more than 1000 catheters. J Burn Care Res 2006;27:713?8.250. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous central venouscatheterization in a pediatric intensive care unit: a survival analysis of complications. Crit Care Med 1989;17:984?8.251. Goldstein AM, Weber JM, Sheridan RL. Femoral venous access is safe in burned children: an analysis of224 catheters. J Pediatr 1997; 130:442?6.252. Ramos GE, Bolgiani AN, Patino O, et al. Catheter infection risk related to the distance between insertionsite and burned area. J Burn Care Rehabil 2002; 23:266?71.253. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria onpolyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983;18:1061?3.254. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenouscatheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987;258:2396?403.255. Pittet D, Hugonnet S, Harbath S, et al. Effectiveness of a hospital-wide prgramme to improve compliancewith hand hygiene. Lancet 2000; 356:1307?9.256. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.Clin Infect Dis 2000; 31:1001?7.257. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solutionfor vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792?801.258. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: the clinicaland economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 2003;37:764?71.259. Parienti JJ, du Cheyron D, Ramakers M, et al. Alcoholic povidone-iodine to prevent central venous cathetercolonization: a randomized unit-crossover study. Crit Care Med 2004; 32:708?13.260. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheterdressing. A meta-analysis of the infection risks. JAMA 1992; 267:2072?6.261. Gillies D, O’Riordan E, Carr D, O’Brien I, Frost J, Gunning R. Central venous catheter dressings: asystematic review. J Adv Nurs 2003; 44:623?32.262. Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections withchlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009;88:267?72.263. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venouscatheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261?7.264. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstreaminfection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257?66.265. Bassetti S, Hu J, D’Agostino RB Jr., and Sherertz RJ. Prolonged antimicrobial activity of a cathetercontaining chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. AntimicrobAgents Chemother 2001; 45:1535?8.62